Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-19-039770

Director bought 2,000 shares at $19.50 ($39,000)

  • Director acquired 4,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
DOBMEIER ERIC Director 2019-06-27 Purchase +2,000 $19.50 $39,000 16,000 D
DOBMEIER ERIC Director 2019-06-27 Grant or award +4,000 20,000 D
Derivatives
DOBMEIER ERIC Director 2019-06-27 Grant or award · Non-Qualified Stock Option (Right to Buy) +13,000 13,000 D
Open-market purchases · 2,000 sh · avg $19.50 · $39,000
Loading xslF345X03/doc4.xml…